UY00 Stock Chart & Stats
€0.03
<€0.01(25.00%)
At close: 4:00 PM EST
€0.03
<€0.01(25.00%)
Day’s Range― - ―
52-Week Range€0.02 - €0.15
Previous CloseN/A
Volume0.00
Average Volume (3M)66.00
Market Cap
€2.06M
Enterprise Value€1.05
Total Cash (Recent Filing)€598.00
Total Debt (Recent Filing)€389.11K
Price to Earnings (P/E)―
Beta0.88
Next Earnings
Oct 05, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding17,396,345
10 Day Avg. Volume200
30 Day Avg. Volume66
Financial Highlights & Ratios
PEG Ratio0.29
Price to Book (P/B)-0.36
Price to Sales (P/S)0.00
P/FCF Ratio-5.73
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Reduced Cash BurnFree cash flow losses have materially narrowed versus the very large outflows in FY2022–FY2024. A smaller absolute cash burn improves runway and reduces near-term refinancing urgency, increasing the odds management can execute a restructuring or revenue restart over months.
Structural Industry DemandOperating in healthcare information services provides durable structural demand as providers and systems continue to prioritize digital information and analytics. That underlying industry traction supports potential revenue recovery if product-market fit or sales execution improves.
Ongoing Disclosure CadenceA scheduled next earnings release indicates continued public reporting and governance. Regular disclosure gives stakeholders timely visibility into operational progress, financing plans or restructuring steps, enabling clearer oversight and accountability during a multi-month recovery.
Bears Say
Revenue CollapseRevenue near zero eliminates operating scale and renders gross margins and unit economics non-informative. With minimal sales, fixed costs and selling efforts cannot be absorbed, making sustainable profitability dependent on a material and durable revenue reboot or significant restructuring.
Negative Equity And Rising DebtDeeply negative equity and rising debt are structural solvency concerns that constrain financing options and raise recapitalization risk. This weak capital base increases the likelihood of dilution or creditor-driven restructurings over the medium term, limiting strategic flexibility.
Persistent Negative Cash FlowOngoing negative operating and free cash flows mean the business remains dependent on external funding to sustain operations. Even with moderated outflows, persistent cash deficits elevate financing and execution risk and can force cutbacks or dilutive raises within several months if revenues don't resume.
TripSitter Clinic Ltd News
UY00 FAQ
What was TripSitter Clinic Ltd’s price range in the past 12 months?
TripSitter Clinic Ltd lowest stock price was €0.01 and its highest was €0.15 in the past 12 months.
What is TripSitter Clinic Ltd’s market cap?
TripSitter Clinic Ltd’s market cap is €2.06M.
When is TripSitter Clinic Ltd’s upcoming earnings report date?
TripSitter Clinic Ltd’s upcoming earnings report date is Oct 05, 2026 which is in 71 days.
How were TripSitter Clinic Ltd’s earnings last quarter?
Currently, no data Available
Is TripSitter Clinic Ltd overvalued?
According to Wall Street analysts TripSitter Clinic Ltd’s price is currently Overvalued.
Does TripSitter Clinic Ltd pay dividends?
TripSitter Clinic Ltd does not currently pay dividends.
What is TripSitter Clinic Ltd’s EPS estimate?
TripSitter Clinic Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does TripSitter Clinic Ltd have?
TripSitter Clinic Ltd has 17,396,345 shares outstanding.
What happened to TripSitter Clinic Ltd’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of TripSitter Clinic Ltd?
Currently, no hedge funds are holding shares in DE:UY00
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
TripSitter Clinic Ltd
TripSitter Clinic Ltd. operates a consultative virtual clinic and tele-health platform that connects patients to a licensed physician who can evaluate for a prescribed treatment program of low-dose oral ketamine medication in the United States. Its platform covers treatment for depression, anxiety, post-traumatic stress disorders, bipolar disorders, and obsessive-compulsive disorders. The company’s treatment subscription plan includes consultation with a physician, oral ketamine prescription medication, treatment sessions with a licensed medical practitioner, and messaging with a licensed medical practitioner. It serves clients in Arizona, California, Colorado, Florida, Georgia, Illinois, Iowa, Kentucky, Maine, Michigan, Minnesota, Mississippi, Montana, Nebraska, New Hampshire, North Dakota, Oklahoma, Tennessee, Vermont, Washington, West Virginia, Wisconsin, and Wyoming. TripSitter Clinic Ltd. is headquartered in Toronto, Canada.
Technical Analysis
Vitalhub
―
―
Rocket Doctor AI
―
Comprehensive Healthcare Systems Inc
―
UniDoc Health Corp
―